Found 108 matching trials
Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer PHASE4 The aim of this study was to evaluate the efficacy, safety and tolerability...
Show More Location
Breast Cancer Center Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences
Learn More & Join Trial
Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study. PHASE2 This is a multicenter, two-arm, exploratory clinical study designed to eval...
Show More Location
The Fourth Hospital of Hebei Medical University
Learn More & Join Trial
Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel. PHASE3 This is a randomized, double-blind, multicenter trial,parallel control desi...
Show More Location
Fudan University Cancer Hospital
Learn More & Join Trial
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
A Study of Trastuzumab Emtansine (T-DM1) in Combination With Docetaxel, and Potentially Pertuzumab, in Participants With Advanced Breast Cancer PHASE1 This is an open-label, multi-center, non-randomized study of the safety and...
Show More Location
Multiple Locations
Learn More & Join Trial
Trastuzumab & Pertuzumab Followed by T-DM1 in MBC PHASE2 In HER2-positive metastatic breast cancer, trastuzumab based treatment is t...
Show More Location
Hopital Sud - Amiens
Learn More & Join Trial
Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer PHASE2 The purpose of this trial is to evaluate efficacy and toxicity of either th...
Show More Status
Active Not Recruiting
Location
Dept. of Oncology, Örebro University Hospital
Learn More & Join Trial
A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer PHASE2 This 3 arm study will assess the tolerability, safety and efficacy of 3 neo...
Show More Location
Multiple Locations
Learn More & Join Trial
IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer PHASE3 This is a randomized, multicenter, open-label, phase 3 study evaluating the...
Show More Location
Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial